Advertisement

AGE

, Volume 20, Issue 3, pp 141–149 | Cite as

Effect of the antioxidant action of Ginkgo biloba extract (EGb 761) on aging and oxidative stress

  • M. T. Droy-Lefaix
Article

Abstract

Aging is responsible for oxidative damage to DNA, protein, lipid, and other macromolecules linked to tissue alterations. The resultant damage contributes significantly to degenerative diseases, to include those of the brain, sensorial tissues, and cardiovascular system. To protect cellular components from oxyradical attack, especially lipoperoxidation, a substantial interest in the use of antioxidants has evolved. A free radical scavenger, Ginkgo biloba extract (EGb 761) may be effective in fighting the oxidative stress related to aging. Many data support the efficacy of EGb 761 in biological model systems. In aging processes, EGb 761 may ameliorate the mitochondria respiratory chain function by quenching the superoxide anion, and the hydroxyl and peroxyl radicals. It protects the brain by facilitating the uptake of neurotransmitters and by reducing ischemia-reperfusion episodes and level of apoptosis. Moreover, in sensorial tissues, EGb 761 reduces apoptosis in the olfactive bulb and in the retinal pigmented epithelium of the eye, and protects against the lipoperoxidation alteration of the retina that results in a decrease of the electroretinogram response. In the cardiovascular system, by a direct effect on oxidative low density lipoproteins, EGb 761 may decrease atherosclerosis evolution, and is shown to accelerate cardiac mechanical recovery after ischemia-reperfusion. In conclusion, the antioxidant effects of EGb 761 noted in many experimental data, may explain the therapeutic efficacy observed in clinical trials of the elderly. These beneficial properties seem in part to come from the activity of EGb 761 constituents, such as flavonoids and terpens.

Key words

Ginkgo biloba extract Antioxidants Oxidative stress Aging 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ames, B.N., Shigenaga, M.K. and Hagen, T.M.: Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl. Acad. Sci., 90: 7915–7922, 1993.PubMedGoogle Scholar
  2. 2.
    de Groot, H.: Reactive oxygen species in tissue injury. Hepato-Gastroenterol., 41: 328–332, 1994.Google Scholar
  3. 3.
    Dianzani, M.V.: Free radicals in physiology and pathology. Boll. Soc. It. Biol. Sper., LXVIII: 491–511, 1992.Google Scholar
  4. 4.
    Zimmerman, J.J.: Oxyradical pathophysiology. Adv. Pediat., 42: 243–302, 1995.Google Scholar
  5. 5.
    Halliwell, B.: Reactive oxygen species and the central nervous system. J. Neurochem., 59: 1609–1623, 1992.PubMedGoogle Scholar
  6. 6.
    Barber, D.A. and Harris, S.R.: Oxygen free radicals and antioxidants: a review. Amer. Pharm., NS34: 26–35, 1994.Google Scholar
  7. 7.
    Beyer, R.E.: The role of ascorbate in antioxidant protection of biomembranes: interaction with vitamin E and coenzyme Q. J. Bioenerg. Biomembrane, 26, 349–358, 1994.CrossRefPubMedGoogle Scholar
  8. 8.
    Halliwell, B.: Free radicals, antioxidants and human disease: curiosity, cause, or consequence? Lancet, 344: 721–724, 1994.CrossRefPubMedGoogle Scholar
  9. 9.
    Landvik, S.V., Diplock, A.J. and Packer, L.: Efficacy of vitamin E in human health and disease, in Handbook of Antioxidants, edited by Cadenas, H. and Packer, L., New York, Marcel Dekker Inc., 1996, pp. 63–87.Google Scholar
  10. 10.
    Barja de Quiroga, G., Lopez-Torres, M. and Perez-Campo, R.: Relationship between antioxidants, lipid peroxidation and aging, in Free Radicals and Aging, edited by Emerit, I. and Chance, B., Basel, Birkhäuser Verlag, 1992, pp. 109–123.Google Scholar
  11. 11.
    Michel, P.F.: Ginkgo biloba: l’arbre qui a vaincu le temps. Paris, Editions du Félin, 1986.Google Scholar
  12. 12.
    Chang, H.M., and But, P.P.H.: Pharmacology and applications of Chinese materia medica. World Scientific Publ. Co, Singapore, 2: 1096–1101, 1987.Google Scholar
  13. 13.
    DeFeudis, F.V.: Ginkgo biloba extract (EGb 761): Pharmacological activities and clinical applications. Paris, Elsevier, 1991.Google Scholar
  14. 14.
    Kleijnen, J. and Knipschild, P.: Ginkgo biloba. Lancet, 340: 1136–1139, 1992.CrossRefPubMedGoogle Scholar
  15. 15.
    Droy-Lefaix, M.T., Baudouin, C., de Kozak, Y. and Doly, M.: Free radicals and antioxidants in pathophysiology of mammalian retina, in Free Radicals in Brain Physiology and Disorders, edited by Packer, P., Hiramatsu, M., and Yoshikawa, T., San Diego, Academic Press, 1996, pp. 359–367.Google Scholar
  16. 16.
    Haramaki, N., Packer, L., Droy-Lefaix, M.T., and Christen, Y.: Antioxidant actions and health implications of Ginkg biloba extract, in Handbook of Antioxidants, edited by Cadenas, E., and Packer, L., New York, Marcel Dekker Inc., 1996, pp. 487–510.Google Scholar
  17. 17.
    Vanhaelen, M., and Vanhaelen-Fastré, R.: Countercurrent chromatography for isolation of flavonol glycosides from Ginkgo biloba leaves. J. Liq. Chromatogr. 11, 2969–2975, 1988.Google Scholar
  18. 18.
    Halliwell, B., and Gutteridge, J.M.C.: Free radicals in biology and medicine. Oxford, Clarendon Press, 1989.Google Scholar
  19. 19.
    Gardès-Albert, M., Ferradini, C., Sekaki, A., and Droy-Lefaix, M.T.: Oxygen-centered free radicals and their interaction with EGb 761 or CP202, in Advances in Ginkgo biloba extract research, Vol. 2, Ginkgo biloba extract (EGb 761) as a free-radical scavenger, edited by Ferradini, C., Droy-Lefaix, M.T., and Christen, Y., Paris, Elsevier, 1993, pp. 1–11.Google Scholar
  20. 20.
    Marcocci, L., Packer, L., Droy-Lefaix, M.T., Sekaki, A.H., and Gardès-Albert, M.: Antioxidant action of Ginkgo biloba extract EGb 761, in Methods in Enzymology, edited by Packer, L., San Diego, Academic Press, 1994, pp. 462–475.Google Scholar
  21. 21.
    Pincemail, J., and Deby, C.: Propriétés antiradicalaires de l’extrait de Ginkgo biloba. Presse Méd., 15: 1475–1479, 1986.PubMedGoogle Scholar
  22. 22.
    Robak, J., and Gryglewski, R.J.: Flavonoids are scavengers of superoxide anions. Biochem. Pharmacol., 37: 837–841, 1988.CrossRefPubMedGoogle Scholar
  23. 23.
    Husain, S.R., Cillard, J., and Cillard, P.: Hydroxyl radical scavenging activity of flavonoids. Phytochemistry, 26: 2489–2491, 1987.CrossRefGoogle Scholar
  24. 24.
    Bors, W., Heller, W., Michel, C., and Saran, M.: Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol., 189: 343–355, 1990.CrossRefGoogle Scholar
  25. 25.
    Sichel, G., Corsaro, C., Scalia, M., Di Bilio, A.G., and Bonomo, R.P.: In vitro scavenger activity of some flavonoids and melamino against O2.-. Free Rad. Biol. Med., 11: 1–8, 1991.CrossRefPubMedGoogle Scholar
  26. 26.
    Dumont, E., Petit, E., Tarrade, T., and Nouvelot, A.: UV-C irradiation-induced peroxidative degradation of microsomal fatty acid and proteins: protection by an extract of Ginkgo biloba (EGb 761). Free Rad. Biol. Med., 13: 197–203, 1992.CrossRefPubMedGoogle Scholar
  27. 27.
    Maitra, I., Marcocci, L., Droy-Lefaix, M.T., and Packer, L.: Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem. Pharmacol., 49: 1649–1665, 1995.CrossRefPubMedGoogle Scholar
  28. 28.
    Yuting, C., Rongliang, Z., Zhongjian, J., and Yong, J.: Flavonoids as superoxide scavengers and antioxidants. Free Rad. Biol. Med., 9: 19–21, 1990.CrossRefGoogle Scholar
  29. 29.
    Marcocci, L., Maguire, J.J., Droy-Lefaix, M.T., and Packer, L.: The nitric oxide-scavenging properties of Ginkgo biloba extract, EGb 761. Biochem. Biophys. Res. Comm., 201: 748–755, 1994.CrossRefPubMedGoogle Scholar
  30. 30.
    Harman, D.: Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11: 298–300, 1956.PubMedGoogle Scholar
  31. 31.
    Benzi, G., and Moretti, A.: Age-and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Rad. Biol. Med., 19: 77–101, 1995.CrossRefPubMedGoogle Scholar
  32. 32.
    Wallace, D.C.: Disease of the mitochondrial DNA. Ann. Rev. Biochem., 61: 1175–1212, 1992.CrossRefPubMedGoogle Scholar
  33. 33.
    Wallace, D.C.: Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science, 256: 628–632, 1992.PubMedGoogle Scholar
  34. 34.
    Bowling, A.C., Mutisya, E.M., Walker, L.C., Price, D.L., Cork, L.C., and Beal, M.F.: Age-dependent impairment of mitochondrial function in primate brain. J. Neurochem., 60: 1964–1967, 1993.PubMedGoogle Scholar
  35. 35.
    Trounce, I., Byr, N.E., and Marzuki S.: Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in aging. Lancet, 1: 637–639, 1989.CrossRefPubMedGoogle Scholar
  36. 36.
    Welt, K., Fitz, F., and Schaffranietz, L.: Ginkgo biloba extract (EGb 761) protects ultrastructure of hypoxic myocardium in elderly rats, in Proceedings of the International Symposium on Natural Antioxidants. Molecular Mechanisms and Health Effects, edited by Packer, L., Traber, M.G., and Xin, W., Champaign (IL), AOCS Press, 1995, pp. 424–433.Google Scholar
  37. 37.
    Sastre, J., Millan, A., de la Asuncion, J.G., Pallardo, F.V., Droy-Lefaix, M.T., and Vinal, J.: Prevention of age-associated mitochondrial DNA damage by Ginkgo biloba extract EGb 761, in Proceedings of the VIII Biennial Meeting International Society for Free Radical Research, Barcelona, J.R. Prous, (in press).Google Scholar
  38. 38.
    Spinnewyn, B., Blavet, N., and Drieu, K.: Effect of Ginkgo biloba extract (EGb 761) on oxygen consumption by isolated cerebral mitochondria, in Advances in Ginkgo biloba Extract Research, Vol. 4, Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-related Disorders, edited by Christen, Y., Courtois Y., and Droy-Lefaix, M.T., Paris, Elsevier, 1995, pp. 17–22.Google Scholar
  39. 39.
    Demopoulos, H., Flamm, E., Seligman, M., Power, R., Pietronigro, D., and Ransohoff, J.: Molecular pathology of lipids in CNS membranes, in Oxygen and Physiological Function, edited by Jöbsis, F.F., Dallas (TX), Professional Information Library, 1977, pp. 491–508.Google Scholar
  40. 40.
    Pastuszko, A., Gordon-Majozak, W., and Dabrowiecki, Z.: Dopamine uptake in striatal synaptosomes exposes to peroxidation “in vitro”. Biochem. Pharmacol., 32: 141–146, 1983.CrossRefPubMedGoogle Scholar
  41. 41.
    Dumont, E., Petit, E., d’Arbigny, P., Tarrade, T., and Nouvelot A.: Ginkgo biloba extract (EGb 761) protects membrane polyunsaturated fatty acids and proteins against degradation induced by UV-C irradiation, in Advances in Ginkgo biloba extract, Vol. 2, Ginkgo biloba extract (EGb 761) as a free radical scavenger, edited by Ferradini, C., Droy-Lefaix, M.T., and Christen, Y., Paris, Elsevier, 1993, pp. 173–184.Google Scholar
  42. 42.
    Ramassamy, C., Christen, Y., Clostre, F., and Costentin, J.: The ginkgo biloba extract (EGb 761) increases synaptosomal uptake of 5 hydroxy tryptamine; in vitro and ex vivo studies. J. Pharm. Pharmacol., 44: 943–945, 1992.PubMedGoogle Scholar
  43. 43.
    Huguet, F., Drieu, K., Tarrade, T., and Piriou, A.: Cerebral adrenergic and serotoninergic receptor loss in rats during aging can be reversed by Ginkgo biloba extract (EGb 761), in Advances in Ginkgo biloba extract research, Vol. 4, Effects of Ginkgo biloba extract (EGb 761 ) on aging and age-related disorders, edited by Christen, Y., Courtois, Y., and Droy-Lefaix, M.T., Paris, Elsevier, 1995, pp. 77–88.Google Scholar
  44. 44.
    Heron, D.S., Schinitzky, M., Hershkowitz, M., and Samuel, D.: Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc. Natl. Acad. Sci. USA, 77: 7463–7467, 1980.PubMedGoogle Scholar
  45. 45.
    Tricklebank, M.P., Forler, C., Fozard, J.R.: The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2 (din-propylamino) tretralin in the rat. Eur. J. Pharmacol., 106: 271–282.Google Scholar
  46. 46.
    Sram, R.J., Binkova, B., Stejskalova, J., and Topinka, J.: Effect of EGb 761 on lipid peroxidation, DNA repair and antioxienzyme activity, in Advances in Ginkgo biloba Extract Research, Vol. 2, Ginkgo biloba Extract (EGb 761) as a Free Radical Scavenger, edited by Ferradini, C., Droy-Lefaix, M.T., and Christen, Y., Paris, Elsevier, 1993, pp. 27–38.Google Scholar
  47. 47.
    Holgado-Madruga, M., de Castro, S., and Macias-Nunez, J.F.: Effects of Ginkgo biloba extract (EGb 761) on brain aging and oxygen free-radical metabolism in the rat, in Advances in Ginkgo biloba Extract Research, Vol. 4, Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-related Disorders, edited by Christen, Y., Courtois, Y., and Droy-Lefaix, M.T., Paris, Elsevier, 1995, pp. 71–76.Google Scholar
  48. 48.
    Halliwell, B.: Oxygen radicals as key mediators in neurological disease: fact or fiction. Ann. Neurol., 32: 910–915, 1992.CrossRefGoogle Scholar
  49. 49.
    Siesjö, B.K.: A new perspective of ischemic brain?, in Neurobiology of Ischemic Brain Damage, edited by Kogure, K., Hossman, K.A., and Siesjö, B.K., Amsterdam, Elsevier, 1993, pp. 1–9.Google Scholar
  50. 50.
    Spinnewyn, B., Blavet, N., and Clostre, F.: Effets de l’extrait de Ginkgo biloba sur un modèle d’ischémie cérébrate chez la gerbille. Presse. Med., 15: 1511–1515, 1986.PubMedGoogle Scholar
  51. 51.
    Lavin, M.F., Baxter, G.D., Song, Q, Findik, D., and Kovacs, E.: Protein modification in apoptosis, in Programmed Cell Death, the Cellular and Molecular Biology of Apoptosis, edited by Lavin, M., and Watters, D., Brisbane, Harwood Academic Pub., 1993, pp. 45–57.Google Scholar
  52. 52.
    Tomei, D.L., and Cope, F.O.: Apoptosis. The molecular basis of cell death. Current communications in cell and molecular biology, New York, Cold Spring Harbor Press, 1991.Google Scholar
  53. 53.
    Slater, A.F.G, and Orrenius, S.: Oxidative stress and apoptosis, in Oxidative Stress and Aging, edited by Cutler, R.G., Packer, L., Bertram, J., and Morri, A., Basel, Birkhaüser Verlag, 1995, pp. 21–26.Google Scholar
  54. 54.
    Selkoe, D.J.: The molecular pathology of Alzheimer’s disease. Neurons, 6: 487–498, 1991.CrossRefGoogle Scholar
  55. 55.
    Buttke, T.M., and Sandstrom, P.A.: Oxidative stress as a modulator of apoptosis. Immunol. Today, 15: 7–10, 1994.CrossRefPubMedGoogle Scholar
  56. 56.
    Didier, A., Rouiller, D., Coronas, V., Jourdan, F., and Droy-Lefaix, M.T.: Effects of Ginkgo biloba extract (EGb 761) on apoptosis and regeneration of primary olfactory neurons following target “lesioning” in rats, in Advances in Ginkgo biloba Extract Research, Vol. 5, Effects of Ginkgo biloba Extract (EGb 761) on Neuronal Plasticity, edited by Christen, Y., Droy-Lefaix, M.T., and Macias-Nunez, J.F., Paris, Elsevier, 1996, pp. 45–52.Google Scholar
  57. 57.
    Del Maestro, R.F., Thaw, H.H., Bjork, J., Planker, M., and Arfors, K.E.: Free radicals as mediators of tissue injury. Acta Physiol. Scand., 492: 43–57, 1980.Google Scholar
  58. 58.
    Szabo, M.E., Droy-Lefaix, M.T., Doly, M., and Braquet, P.: Free radical-mediated effects in reperfusion injury: an histologic study with superoxide dismutase and EGb 761 in rat retina. Ophthalmic Res., 23: 225–234, 1991.PubMedCrossRefGoogle Scholar
  59. 59.
    Szabo, M.E., Droy-Lefaix, M.T., Doly, M., Carré, C., and Braquet, P.: Ischemia and reperfusion-induced histologic changes in the rat retina. Demonstration of a free-radical mediated mechanism. Invest. Ophthalmol. Vis. Sci., 32: 1471–1478, 1991.PubMedGoogle Scholar
  60. 60.
    Szabo, M.E., Droy-Lefaix, M.T., Doly, M., and Braquet, P.: Modification of ischemia-reperfusion-induced ion shifts (Na+, K+, Ca2+, Mg2+). Ophthalmic Res., 25: 1–9, 1993.PubMedGoogle Scholar
  61. 61.
    Menerath, J.M., Cluzel, J., Droy-Lefaix, M.T., and Doly, M.: Electroretinographic assessment of a free radical scavenger (EGb 761) treatment on rat retinal ischemia. Invest. Ophthalmol. Vis. Sci., 36: S934, 1995.Google Scholar
  62. 62.
    Menerath, J.M., Doly, M., Droy-Lefaix, M.T., Besse, G., and Vennat, J.: Evaluation electroretinographique et histologique de l’ischémie rétinienne chez le rat par hypertonie intra-oculaire. Ophtalmologie, 9: 291–300, 1995.Google Scholar
  63. 63.
    Behar-Cohen, F.F., Heydolph, S., Faure, V., Droy-Lefaix, M.T., Courtois, Y., and Goureau, O.: Peroxynitrite cytotoxicity on bovine retinal pigmented epithelial cells in culture. Biochem. Biophys. Res. Comm., 226: 842–849, 1996.CrossRefPubMedGoogle Scholar
  64. 64.
    Droy-Lefaix, M.T., Bonhomme, B., and Doly, M.: A protective effect of EGb 761 on aging rat retina. Invest. Ophthalmol. Vis. Sci., 36: S855, 1995.Google Scholar
  65. 65.
    Esterbauer, H., Gebicki, J., Puhl, H., and Jürgens, G.: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. Med., 13: 341–390, 1992.CrossRefPubMedGoogle Scholar
  66. 66.
    Fortun, A., Khalil, A., Bonnefont-Rousselot, D., Gardès-Albert, M., Lepage, S., Delattre, J., and Droy-Lefaix, M.T.: Effect of EGb 761 on the peroxidation of human low-density lipoproteins (LDL) initiated by oxyradicals generated by water radiolysis. J. Chim. Phys., 91: 1078–1084, 1994.Google Scholar
  67. 67.
    McCord, J.M.: Oxygen-derived free radicals in post ischemic tissue injury. N. Engl. J. Med., 312: 159–163, 1985.PubMedCrossRefGoogle Scholar
  68. 68.
    Blasig, I.E., Ebert, B., Hennig, C., Pali, T., and Tosaki, A.: Inverse relationship between ESR spin trapping of oxyradicals and degree of functional recovery during myocardial reperfusion in isolated working rat heart. Cardiovasc. Res., 24: 263–270, 1990.PubMedCrossRefGoogle Scholar
  69. 69.
    Terada, L.S., Rubinstein, J.D., Lesnefsky, E.J., Horwitz L.D., Left, J.A., and Repine, J.E.: Existence and participation of xanthine-oxidase in reperfusion injury of ischemic rabbit myocardium. Am. J. Physiol., 260: H805–H810, 1991.PubMedGoogle Scholar
  70. 70.
    Packer, L., Haramaki, N., Kawabata, T., Marcocci, L., Maitra, I, Maguire, J.J., Droy-Lefaix, M.T., Sekaki, A.H., and Gardès-Albert, M.: Ginkgo biloba extract (EGb 761); antioxidant action and prevention of oxidative stress-induced injury, in Advances in Ginkgo biloba Extract Research, Vol. 4, Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-related Disorders, edited by Christen Y., Courtois, Y., and Droy-Lefaix, M.T., Paris, Elsevier, 1995, pp. 23–47.Google Scholar
  71. 71.
    Packer, L.: Oxidative stress, antioxidants aging and disease, in Oxidative Stress and Aging, edited by Cutler, R.G., Packer, L., Bertram, J., and Morri, A., Basel, Birkhaüser Verlag, 1995, pp. 1–14.Google Scholar
  72. 72.
    Culcasi, M., Pietri, S., Carriere, I., d’Arbigny, P., and Drieu, K.: Electron-spin-resonance study of the protective effects of Ginkgo biloba extract (EGb 761) on reperfusion-induced free radical generation associated with plasma ascorbate consumption during open-out surgery in man, in Advances in Ginkgo biloba Extract Research, Vol. 2, Ginkgo biloba Extract (EGb 761) as a Free Radical Scavenger, edited by Ferradini, C., Droy-Lefaix, M.T., and Christen, Y., Paris, Elsevier, 1993, pp. 153–162.Google Scholar
  73. 73.
    Taillandier, J., Ammar, A, Rabourdin, J.P., Ribeyre, J.P., Pichon, J., Niddam, S., and Pierart, H.: Ginkgo biloba extract in the treatment of cerebral disorders due to aging. Longitudinal, multicenter, double-blind study versus placebo, in Rökan (Ginkgo biloba) Recent Results in Pharmacology and Clinic, edited by Fünfgeld, E.W., Berlin, Springer-Verlag, 1988, pp. 291–301.Google Scholar
  74. 74.
    Allain, H., Lieury, A., Gandon, J.M., and d’Arbigny, P.: The dual-coding test in elderly subjects: psychometric assessment of properties of Ginkgo biloba extract (EGb 761), in Advances in Ginkgo biloba Extract Research, Vol. 4, Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-Related Disorders, edited by Christen, Y., Courtois, Y., and Droy-Lefaix, M.T., Paris, Elsevier, pp. 131–139.Google Scholar
  75. 75.
    Israël, L., Myslinski, M., Dell’Accio, E., Lambert, C., and Hugonot, R.: Onset of memory disorders: specific and combined contributions of memory-training programs and Ginkgo biloba extract (EGb 761) treatment, in Advances in Ginkgo biloba Extract Research, Vol. 4, Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-Related Disorders, edited by Christen, Y., Courtois, Y. and Droy-Lefaix, M.T., Paris, Elsevier, 1995, pp. 119–129.Google Scholar
  76. 76.
    Hofferberth, B.: Influence of Ginkgo biloba Extract (EGb 761) on neurophysiological and neuropsychological measurements in patients suffering from psychoorganic syndrome, in Advances in Ginkgo biloba Extract Research, Vol. 4, Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-Related Disorders, edited by Christen, Y., Courtois, Y., and Droy-Lefaix, M.T., Paris, Elsevier, 1995, pp. 141–148.Google Scholar
  77. 77.
    Kanowski, S.: Proof of efficacy of the Ginkg biloba special extract (EGb 761) in outpatients suffering from primary degenerative dementia of the Alzheimer type and multi-infarct dementia., in Advances in Ginkgo biloba Extract Research, Vol. 4, Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-Related Disorders, edited by Christen, Y., Courtois, Y., and Droy-Lefaix, M.T., Paris, Elsevier, 1995, pp. 149–158.Google Scholar

Copyright information

© American Aging Association, Inc. 1997

Authors and Affiliations

  • M. T. Droy-Lefaix
    • 1
  1. 1.Institut IPSENParisFrance

Personalised recommendations